PR inside: MREO ALERT: Levi & Korsinsky Investigates Mereo BioPharma Group plc ...
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / July 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Mereo BioPharma Group plc ("Mereo BioPharma Group plc") (NASDAQ:MREO) concerning possible violations of federal securities laws.
Mereo and its development partner Ultragenyx Pharmaceutical Inc. issued a press release on July 9, 2025, "announcing that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis[.]" Following a Data Monitoring Committee meeting, the two companies advised that the final analysis would ..
https://reports.pr-inside.com/mreo-aler ... 121539.htm
Copyright PR-Inside.com 2025